1.00

15.59% 0.1349

Pre-market: .98 -0.02 -2.00%

Biofrontera Inc (BFRI)

Overview News Price History Financials Discussions Forecast Stock Split

Biofrontera Inc stock is traded at $1.00, with a volume of 702.22K. It is up +15.59% in the last 24 hours and up +25.00% over the past month. Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Previous Close:

$0.8651

Open:

$0.867

24h Volume:

702.22K

Relative Volume:

4.25

Market Cap:

$12.80M

Revenue:

$43.20M

Net Income/Loss:

$-11.09M

P/E Ratio:

-0.9019

EPS:

-1.1088

Net Cash Flow:

$-9.32M

1W Performance:

+7.53%

1M Performance:

+25.00%

6M Performance:

+26.58%

1Y Performance:

+51.75%

1-Day Range:

$0.867

$1.03

1-Week Range:

$0.84

$1.03

52-Week Range:

$0.5547

$1.19

Biofrontera Inc Stock (BFRI) Company Profile

Name

Biofrontera Inc

Sector

Healthcare (1104)

Industry

Drug Manufacturers - Specialty & Generic (88)

Phone

781-245-1325

Address

120 PRESIDENTIAL WAY,, WOBURN

Employee

Twitter

Next Earnings Date

2026-05-14

Latest SEC Filings

BFRI's Discussions on Twitter

Compare BFRI vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BFRI Biofrontera Inc	1.00	12.80M	43.20M	-11.09M	-9.32M	-1.1088
TAK Takeda Pharmaceutical Co Adr	15.77	49.83B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.07	40.04B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	33.69	39.23B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	79.95	33.52B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	549.57	23.33B	3.17B	1.29B	1.01B	27.09

Biofrontera Inc Stock (BFRI) Latest News

Jun 11, 2026

BFRI News | BIOFRONTERA INC (NASDAQ:BFRI) - ChartMill

Jun 11, 2026

BFRI: All proposals, including director elections and plan amendments, were approved by shareholders - TradingView

Jun 11, 2026

Number of shareholders of Biofrontera Inc. – BOATS:BFRI - TradingView

Jun 11, 2026

Jun 08, 2026

Biofrontera Inc. Warrants (BFRIW) Stall at $0.03 as Trading Range TightensVolatility Stop - newsline.com

Jun 08, 2026

Jun 07, 2026

BFRI Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock DeclinesHealthcare Earnings Report - newsline.com

Jun 07, 2026

Jun 05, 2026

BFRI Q1 2026 Earnings: Steep EPS Miss Weighs on Shares as Revenue Remains UnreportedGAAP Earnings Report - newsline.com

Jun 05, 2026

Jun 03, 2026

BFRI Q1 2026 Earnings: Wider-than-Expected Loss as Stock Rises on Strategic ProgressRevenue Miss Report - newsline.com

Jun 02, 2026

May 31, 2026

Number of shareholders of Biofrontera Inc. – NASDAQ:BFRIW - TradingView

May 31, 2026

May 29, 2026

PTA-News: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FIRST QUARTER OF 2026 - TradingView

May 29, 2026

May 28, 2026

BFRI: Revenue and margins are rising as new indications and regulatory milestones drive future growth - TradingView

May 28, 2026

REX: Fiscal Q1 Earnings Snapshot - AOL.com

May 28, 2026

May 27, 2026

Squires Says Sun PGR Petition Denied For Not Naming Parent - Law360

May 27, 2026

Biofrontera Inc. Warrants (BFRIW) Surge Over 19% as Speculative Interest ReturnsInvestment Factor - The Legal Advocate

May 27, 2026

Ellomay: Q1 Earnings Snapshot - AOL.com

May 27, 2026